TNFSF11 and irritable bowel syndrome: This being said, it appears to be mechanisms that intrinsically affect bone metabolic activity in patients with IBD such as the chronic inflammatory state in IBD leading to bone loss through Tumor necrosis factor (TNF) alpha RANK/RANKL/osteoprotegerin system activation, which promotes osteoclastogenesis [5].